Yuko Chiba

1.4k total citations
63 papers, 1.0k citations indexed

About

Yuko Chiba is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yuko Chiba has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 13 papers in Molecular Biology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yuko Chiba's work include Frailty in Older Adults (10 papers), Nutrition and Health in Aging (9 papers) and Diabetes Management and Research (5 papers). Yuko Chiba is often cited by papers focused on Frailty in Older Adults (10 papers), Nutrition and Health in Aging (9 papers) and Diabetes Management and Research (5 papers). Yuko Chiba collaborates with scholars based in Japan, United States and Australia. Yuko Chiba's co-authors include Yoshiaki Tamura, Katsuyuki Ando, Atsushi Araki, Seijiro Mori, Toshiro Fujita, Hideki Ito, Hideyuki Sakoda, Midori Fujishiro, Tomoichiro Asano and Hiraku Ono and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Yuko Chiba

55 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Chiba Japan 17 294 269 241 150 141 63 1.0k
Yunfeng Xiao China 15 216 0.7× 256 1.0× 154 0.6× 120 0.8× 92 0.7× 45 822
Zoran Gluvić Serbia 20 223 0.8× 259 1.0× 334 1.4× 129 0.9× 145 1.0× 63 1.1k
Ana Jover Spain 19 261 0.9× 376 1.4× 312 1.3× 105 0.7× 201 1.4× 25 1.2k
Hongmei Wu China 18 254 0.9× 257 1.0× 192 0.8× 121 0.8× 74 0.5× 73 1.2k
Athanasios Raptis Greece 15 140 0.5× 256 1.0× 323 1.3× 116 0.8× 103 0.7× 39 1.0k
Sabine Allam Lebanon 7 231 0.8× 274 1.0× 311 1.3× 150 1.0× 89 0.6× 11 1.1k
Sang‐Hyun Lee South Korea 20 239 0.8× 296 1.1× 160 0.7× 191 1.3× 116 0.8× 63 973
Yu Hu China 19 322 1.1× 453 1.7× 342 1.4× 243 1.6× 174 1.2× 55 1.4k
Wenyan Lai China 20 269 0.9× 561 2.1× 150 0.6× 222 1.5× 166 1.2× 91 1.2k
Soudabeh Fallah Iran 21 188 0.6× 389 1.4× 128 0.5× 173 1.2× 101 0.7× 90 1.2k

Countries citing papers authored by Yuko Chiba

Since Specialization
Citations

This map shows the geographic impact of Yuko Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Chiba more than expected).

Fields of papers citing papers by Yuko Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Chiba. The network helps show where Yuko Chiba may publish in the future.

Co-authorship network of co-authors of Yuko Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Chiba. A scholar is included among the top collaborators of Yuko Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Chiba. Yuko Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiba, Yuko, et al.. (2024). Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2‐month‐old infant. Pediatric Blood & Cancer. 71(6). e30953–e30953.
2.
Toyoshima, Kenji, Yoshiaki Tamura, Kazuhito Oba, et al.. (2024). Risk factor of disability as new certification of long‐term care needs in older Japanese adults with diabetes mellitus: A longitudinal study. Geriatrics and gerontology international. 24(10). 1030–1038.
3.
Oba, Kazuhito, Joji Ishikawa, Yoshiaki Tamura, et al.. (2024). Serum Growth Differentiation Factor 15 Levels Predict the Incidence of Frailty among Patients with Cardiometabolic Diseases. Gerontology. 70(5). 517–525. 5 indexed citations
4.
Oba, Kazuhito, Kenji Toyoshima, Yuko Chiba, et al.. (2024). Adrenal Insufficiency and Thyrotoxicosis Following Combined Immune Checkpoint Inhibitor Use: A Case Report and Literature Review. Cureus. 16(5). e60850–e60850. 1 indexed citations
7.
Toyoshima, Kenji, Satoshi Seino, Yoshiaki Tamura, et al.. (2022). Difference between “Physical Fitness Age” Based on Physical Function and Chronological Age Is Associated with Obesity, Hyperglycemia, Depressive Symptoms, and Low Serum Albumin. The journal of nutrition health & aging. 26(5). 501–509. 10 indexed citations
8.
Tamura, Yoshiaki, Keigo Shimoji, Joji Ishikawa, et al.. (2022). Association between white matter alterations on diffusion tensor imaging and incidence of frailty in older adults with cardiometabolic diseases. Frontiers in Aging Neuroscience. 14. 912972–912972. 3 indexed citations
9.
Toyoshima, Kenji, Atsushi Araki, Yoshiaki Tamura, et al.. (2020). Use of Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items (DASC‐8) for the screening of frailty and components of comprehensive geriatric assessment. Geriatrics and gerontology international. 20(12). 1157–1163. 10 indexed citations
10.
Oba, Kazuhito, Joji Ishikawa, Yoshiaki Tamura, et al.. (2020). Serum growth differentiation factor 15 level is associated with muscle strength and lower extremity function in older patients with cardiometabolic disease. Geriatrics and gerontology international. 20(10). 980–987. 32 indexed citations
11.
Oba, Kazuhito, Yuko Chiba, Yoko Matsuda, et al.. (2020). Primary Aldosteronism Associated with Multiple Adrenocortical Micronodules in a Patient with Renal Cell Carcinoma. Case Reports in Endocrinology. 2020(1). 2808101–2808101. 1 indexed citations
12.
Miura, Yuri, Shohei Kikuchi, Hiroki Tsumoto, et al.. (2019). Fumarate accumulation involved in renal diabetic fibrosis in Goto-Kakizaki rats. Archives of Biochemistry and Biophysics. 678. 108167–108167. 9 indexed citations
13.
Chiba, Yuko, Ken Sato, Yoshiaki Tamura, et al.. (2015). Risk factors associated with falls in elderly patients with type 2 diabetes. Journal of Diabetes and its Complications. 29(7). 898–902. 63 indexed citations
14.
Fukaya, Makiko, Yoshiaki Tamura, Yuko Chiba, et al.. (2013). Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced β-cell damage and diabetes in mice. Biochemical and Biophysical Research Communications. 442(1-2). 92–98. 20 indexed citations
15.
Tamaki, Junko, Masayuki Iki, E. Kadowaki, et al.. (2012). Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporosis International. 24(3). 887–897. 27 indexed citations
16.
Tamura, Yoshiaki, Yuko Chiba, Toshihiro Tanioka, et al.. (2011). NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells. FEBS Letters. 585(19). 3058–3064. 27 indexed citations
17.
18.
UEDA, Hideo, Kôichi Hayashi, Nobuaki Nakashima, et al.. (2005). Reassessment of ecotoxicities of 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane in Japanese quail under the OECD draft new avian one-generation reproduction test guideline. Regulatory Toxicology and Pharmacology. 41(3). 167–174. 6 indexed citations
19.
Chiba, Yuko, Katsuyuki Ando, & Toshiro Fujita. (2002). The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats. Journal of Hypertension. 20(11). 2269–2274. 23 indexed citations
20.
Chiba, Yuko, et al.. (2001). PPARγ Ligands Inhibit TNF-α-Induced LOX-1 Expression in Cultured Endothelial Cells. Biochemical and Biophysical Research Communications. 286(3). 541–546. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026